-
Study aim
-
Determine the effect of Okra powder on blood glucose levels in women with Gestational Diabetes Mellitus under diet therapy
-
Design
-
A Phase 3 clinical trial, with a control group, no blinding, randomized allocation, 90 pregnant women with Gestational Diabetes Mellitus will be eligible. Cluster sampling and available on women with Gestational Diabetes Mellitus that Dietary therapy confirmed through tests, will be referred to Mashhad Health Centers.
-
Settings and conduct
-
Lack of blinding and sachet packaging will be done by researcher. Research units will be Women with gestational diabetes eligible referred to Mashhad health centers.At baseline, the end of the second and fourth weeks, fasting and two hours after meal blood glucose test will be done.
-
Participants/Inclusion and exclusion criteria
-
Willingness to participate, Reading and writing Literacy, Iranian and Residing in Mashhad, Having phone number, Singleton pregnancy, Gestational age between 24 and 28 weeks, Disrupting oral glucose tolerance test result at 24-28 weeks, Having Fasting Blood Glucose less than 95 mg/dL and two hours after meals less than 120 mg/dL in a test to confirm the treatment of gestational diabetes with diet, No addiction opiate, Lack of medical illness and obstetrics problems, Not attending Psychiatrists in the last six months, Lack of overt diabetes, No history of allergy to Okra and Malvacea family, Lack of Bronchitis, lack of speech and behavioral disorders.
-
Intervention groups
-
Routine care includes usual gestational diabetes diet Will be taught to both groups.The intervention group daily receives 3 grams sachets of okra powder twice a day with breakfast and lunch meals plus a glass of ordinary water(not very cold or very warm) for 4 weeks.The control group will receive routine care that includes the training usual gestational diabetes diet.
-
Main outcome variables
-
Fasting and two hours after a meal blood glucose